Finoriq

Finoriq research workspace

Medpace Holdings, Inc. (MEDP) Institutional Holdings & 13F Ownership

Medpace Holdings, Inc. provides clinical research-based drug and medical device development. Review MEDP institutional holders, 13F ownership, and position changes on Finoriq.

Company Snapshot

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Company
Medpace Holdings, Inc. (MEDP)
Ticker
MEDP
Market Cap
$15.1B
Latest Price
$528.8
Industry
Biotech & Pharma

Open insider transactions

Medpace Holdings, Inc. (MEDP) Top Institutional Holders

Top current 13F holders indexed for Medpace Holdings, Inc. (MEDP). Latest period 2026-03-31.

RankInvestorValuePortfolioFiling
1Francois RochonCIK 0001641864$123M4.5%Filing2026-05-15
2Vulcan Value PartnersCIK 0001556785$97.5M2.6%Filing2026-05-11
3Ken FisherCIK 0000850529$65.2M0.02%Filing2026-05-05
4Mairs & Power FundsCIK 0001070134$41.2M0.42%Filing2026-05-14
5Terry SmithCIK 0001569205$30.1M0.23%Filing2026-05-15

Live data loads in the app

This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.